Dr. Evins completed her residency in adult psychiatry at the Massachusetts Mental Health Center and Longwood Psychiatry Residency Training Program. In addition, she completed a fellowship in molecular biology at the Mailman Research Center of McLean Hospital, a fellowship in clinical research at the Massachusetts General Hospital, and a Master in Public Health with a concentration in Clinical Effectiveness at the Harvard School of Public Health in 2005. She has been an active member of the MGH Schizophrenia and Depression Clinical and Research Program since 1995.
Dr. Evins’ research interests include pharmacotherapy for nicotine dependence, co-occurring psychiatric and substance use disorders, negative symptoms and cognitive dysfunction in schizophrenia. Additionally, she is studying the effects of various medications on reward responsiveness and other potential biomarkers of vulnerability to addiction and of treatment response.
Dr. Evins has authored articles, book chapters, and reviews concerning topics in this field. Her articles are published in scientific journals, such as American Journal of Psychiatry, Neuropsychopharmacology, Biological Psychiatry, Journal of Clinical Psychopharmacology, and Journal of Neural Transmission.
Dr. Evins has twice been the recipient of the National Alliance for Research on Schizophrenia and Affective Disorders Young Investigator Award, and has been awarded the New Clinical Drug Evaluation Unit Award for Young Investigators sponsored by the National Institute of Mental Health, the Massachusetts Department of Public Health Young Investigator Award and two career development awards from NIDA. She is currently supported by six major grants from NIDA to test novel therapies for nicotine dependence in the general population and in those with co-occurring psychiatric disorders.